Literature DB >> 29123962

Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer.

S Meraviglia1,2, E Lo Presti1,2, M Tosolini3, C La Mendola1,2, V Orlando1,2, M Todaro1,4, V Catalano1, G Stassi5, G Cicero5, S Vieni5, J J Fourniè3, F Dieli1,2.   

Abstract

γδ T cells usually infiltrate many different types of cancer, but it is unclear whether they inhibit or promote tumor progression. Moreover, properties of tumor-infiltrating γδ T cells and those in the corresponding normal tissue remain largely unknown. Here we have studied features of γδ T cells in colorectal cancer, normal colon tissue and peripheral blood, and correlated their levels with clinicopathologic hallmarks. Flow cytometry and transcriptome analyses showed that the tumor comprised a highly variable rate of TILs (5-90%) and 4% γδ T cells on average, with the majority expressing Vδ1. Most Vδ1 and Vδ2 T cells showed a predominant effector memory phenotype and had reduced production of IFN- γ which was likely due to yet unidentified inhibitory molecules present in cancer stem cell secretome. Transcriptome analyses revealed that patients containing abundant γδ T cells had significantly longer 5-year disease free survival rate, suggesting their efficacy in controlling tumor at very early stage.

Entities:  

Keywords:  DFS; IFN-γ; TILs; colon cancer; γδ T cells

Year:  2017        PMID: 29123962      PMCID: PMC5665062          DOI: 10.1080/2162402X.2017.1347742

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  49 in total

Review 1.  Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis.

Authors:  Deborah A Kennedy; Seth J Stern; Myla Moretti; Ilan Matok; Moumita Sarkar; Cheri Nickel; Gideon Koren
Journal:  Cancer Epidemiol       Date:  2010-12-21       Impact factor: 2.984

2.  Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.

Authors:  Christelle Harly; Yves Guillaume; Steven Nedellec; Cassie-Marie Peigné; Hannu Mönkkönen; Jukka Mönkkönen; Jianqiang Li; Jürgen Kuball; Erin J Adams; Sonia Netzer; Julie Déchanet-Merville; Alexandra Léger; Thomas Herrmann; Richard Breathnach; Daniel Olive; Marc Bonneville; Emmanuel Scotet
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

Review 3.  Colorectal cancer.

Authors:  David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling
Journal:  Lancet       Date:  2010-03-20       Impact factor: 79.321

4.  Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.

Authors:  Matilde Todaro; Matilde D'Asaro; Nadia Caccamo; Flora Iovino; Maria Giovanna Francipane; Serena Meraviglia; Valentina Orlando; Carmela La Mendola; Gaspare Gulotta; Alfredo Salerno; Francesco Dieli; Giorgio Stassi
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

5.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Authors:  Matilde Todaro; Mileidys Perez Alea; Anna B Di Stefano; Patrizia Cammareri; Louis Vermeulen; Flora Iovino; Claudio Tripodo; Antonio Russo; Gaspare Gulotta; Jan Paul Medema; Giorgio Stassi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

Review 6.  γδ T cells in cancer.

Authors:  Bruno Silva-Santos; Karine Serre; Håkan Norell
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

7.  Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE.

Authors:  Peng Qiu; Erin F Simonds; Sean C Bendall; Kenneth D Gibbs; Robert V Bruggner; Michael D Linderman; Karen Sachs; Garry P Nolan; Sylvia K Plevritis
Journal:  Nat Biotechnol       Date:  2011-10-02       Impact factor: 54.908

Review 8.  Control of the immune response by pro-angiogenic factors.

Authors:  Thibault Voron; Elie Marcheteau; Simon Pernot; Orianne Colussi; Eric Tartour; Julien Taieb; Magali Terme
Journal:  Front Oncol       Date:  2014-04-02       Impact factor: 6.244

9.  Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites.

Authors:  Francesco Dieli; Fabrizio Poccia; Martin Lipp; Guido Sireci; Nadia Caccamo; Caterina Di Sano; Alfredo Salerno
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

10.  Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells.

Authors:  Matilde Todaro; Serena Meraviglia; Nadia Caccamo; Giorgio Stassi; Francesco Dieli
Journal:  Oncoimmunology       Date:  2013-07-29       Impact factor: 8.110

View more
  42 in total

Review 1.  The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?

Authors:  Domenico Galati; Serena Zanotta; Marialuisa Bocchino; Rosaria De Filippi; Antonio Pinto
Journal:  Cancer Immunol Immunother       Date:  2021-01-01       Impact factor: 6.968

2.  NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Elena Bruni; Alessandra Roberto; Federico S Colombo; Anna Villa; Marita Bosticardo; Ileana Bortolomai; Elena Lo Presti; Serena Meraviglia; Francesco Dieli; Stefania Vetrano; Silvio Danese; Silvia Della Bella; Michele M Carvello; Matteo Sacchi; Giovanni Cugini; Giovanni Colombo; Marco Klinger; Paola Spaggiari; Massimo Roncalli; Immo Prinz; Sarina Ravens; Biagio di Lorenzo; Emanuela Marcenaro; Bruno Silva-Santos; Antonino Spinelli; Domenico Mavilio
Journal:  JCI Insight       Date:  2019-12-19

3.  TGF-β enhances the cytotoxic activity of Vδ2 T cells.

Authors:  Christian Peters; Annika Meyer; Léonce Kouakanou; Julia Feder; Tim Schricker; Marcus Lettau; Ottmar Janssen; Daniela Wesch; Dieter Kabelitz
Journal:  Oncoimmunology       Date:  2018-09-26       Impact factor: 8.110

Review 4.  Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.

Authors:  José Saura-Esteller; Milon de Jong; Lisa A King; Erik Ensing; Benjamin Winograd; Tanja D de Gruijl; Paul W H I Parren; Hans J van der Vliet
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

5.  A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells.

Authors:  Frank Liang; Lisa M Nilsson; Fabian Byvald; Azar Rezapour; Helena Taflin; Jonas A Nilsson; Ulf Yrlid
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 6.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

Review 7.  Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.

Authors:  Benjamin Ruf; Bernd Heinrich; Tim F Greten
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

8.  Cryopreservation of Whole Tumor Biopsies from Rectal Cancer Patients Enable Phenotypic and In Vitro Functional Evaluation of Tumor-Infiltrating T Cells.

Authors:  Frank Liang; Azar Rezapour; Peter Falk; Eva Angenete; Ulf Yrlid
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

Review 9.  Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.

Authors:  Timm Hoeres; Manfred Smetak; Dominik Pretscher; Martin Wilhelm
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561

10.  CD3ε Expression Defines Functionally Distinct Subsets of Vδ1 T Cells in Patients With Human Immunodeficiency Virus Infection.

Authors:  Pádraic J Dunne; Christina O Maher; Michael Freeley; Katie Dunne; Andreea Petrasca; Judy Orikiiriza; Margaret R Dunne; Derval Reidy; Siobhan O'Dea; Aisling Loy; Jim Woo; Aideen Long; Thomas R Rogers; Fiona Mulcahy; Derek G Doherty
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.